The need to reform our assessment of evidence from clinical trials: A commentary
2008
Reforming Evidence Assessment in Clinical Trials
Commentary
Author Information
Author(s): Sean M Bagshaw, Rinaldo Bellomo
Hypothesis
The current system for classifying the quality of evidence in clinical trials needs reform to include additional dimensions.
Conclusion
The study argues for a reform in how evidence from clinical trials is assessed, emphasizing the need to include biological plausibility and other dimensions.
Supporting Evidence
- The commentary highlights that current evidence assessment often overlooks biological plausibility.
- It argues that the existing grading systems for evidence are too simplistic.
- The authors suggest that observational studies should be given more weight in evidence assessment.
Takeaway
This study says we need to change how we look at evidence from medical trials to make sure we're not missing important details.
Potential Biases
Potential bias in evidence assessment due to over-reliance on randomized trials.
Limitations
The commentary does not provide empirical data or specific case studies to support its claims.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website